4//SEC Filing
Wells David R. 4
Accession 0001209191-20-038681
CIK 0001681682other
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 8:22 AM ET
Size
7.7 KB
Accession
0001209191-20-038681
Insider Transaction Report
Form 4
Wells David R.
Chief Financial Officer
Transactions
- Exercise of In-Money
Common Stock
2020-06-23$0.87/sh+5,000$4,350→ 115,003 total - Exercise of In-Money
Warrants
2020-06-23−5,000→ 5,051 totalExercise: $0.87From: 2019-12-11Exp: 2024-12-11→ Common Stock (5,000 underlying)
Holdings
- 24,786(indirect: By StoryCorp Consulting)
Common Stock
Footnotes (1)
- [F1]Includes unvested restricted stock units.
Documents
Issuer
ENDRA Life Sciences Inc.
CIK 0001681682
Entity typeother
Related Parties
1- filerCIK 0001480371
Filing Metadata
- Form type
- 4
- Filed
- Jun 23, 8:00 PM ET
- Accepted
- Jun 24, 8:22 AM ET
- Size
- 7.7 KB